The high frequency of mutations in the genes RB1, TSC1 and FOXA1 in the metastatic samples with few or no concordant cases also suggests these genes are similarly relevant to the biology of metastatic disease. This evidence concerns the gene FOXA1 and metastatic neoplasm.